| 摘要 |
The present invention concerns stable liquid pharmaceutical compositions comprising gamma interferon (IFN-.gamma., also known as immune interferon). The invention specifically covers stabilized aqueous pharmaceutical compositions comprising multiple doses of a therapeutically effective amount of IFN-.gamma. for repeated administration.
|
